Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

Overview
Date Founded

2000

Headquarters

84 OCTOBER HILL ROAD, SUITE 10, HOLLISTON, MA, 017461371

Type of Company

Public

Employees (Worldwide)

434

Industries

Industrial Machinery & Manufacturing
Biotechnology

Company Description

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Contact Data
Trying to get in touch with decision makers at Harvard Bioscience, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Chief Financial Officer

Vice President & General Manager-DSI

Vice President & General Manager, Electrophysiology

Vice President of Sales-Denville Scientific

Vice President, Corporate Controller

Supply Chain Coordinator

Director

Marketing Manager

Product Manager

Board of Directors

President, Healthcare Division at OSI Systems, Inc.

Director, President & Chief Executive Officer at Entegris, Inc.

Former Senior Vice President & Chief Commercial Officer at Thermo Fisher Scientific, Inc.

Director, President & Chief Executive Officer at Harvard Bioscience, Inc.

Former Director, Mergers & Acquisitions Law & Transactions at Corning, Inc.

Former Chief Financial Officer, Treasurer & Senior Vice President at RSA Security LLC

Former Interim Chief Executive Officer at Harvard Bioscience, Inc.

Paths to Harvard Bioscience, Inc.
Potential Connections via
Relationship Science
You
Harvard Bioscience, Inc.
Owners & Shareholders
Details Hidden

First Light Asset Management LLC is an American private company located in Edina, MN. The firm provides investment advice. It was founded in 2013 by Matthew Paul Arens and Brett Thomas Johnson. Matthew Paul Arens has been the CEO since then.

Details Hidden

Adirondack Research & Management (ARM) manages the Adirondack Small Cap Fund. The firm uses middle down research approach to identify attractive industries for investments and then narrows their search to identify the best companies for investment. They focus on out-of-favor companies that are not widely followed by Wall Street or are in transition. ARM seeks to identify companies in sectors with encouraging trends. This typically includes companies with improving balance sheets are improving and strengthening cash flows. ARM also also looks for companies with improving competitive positions due to exciting new products or decreased competitive pressures. The firm also focuses on companies that manage assets wisely. They look for companies with a history of smart acquisitions, sensible share buybacks, debt reduction or that have insiders buying shares along with the firm.

Details Hidden

Bard manages the Bard Micro-cap Value Fund. The firm primarily invests in micro/small-cap US stocks. They invest heavily in the finance sector, but are not limited to any particular sectorBard maintains a low turnover rate.

Recent Transactions
Details Hidden

Harvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Details Hidden

Thomas Scientific LLC purchases Denville Scientific, Inc. from Harvard Bioscience, Inc.

Details Hidden

Capp ApS purchases AHN Biotechnologie GmbH from Harvard Bioscience, Inc.

Transaction Advisors
Auditor

Advised onHarvard Bioscience, Inc. issued Common Stock

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Genomic Solutions, Inc.

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Co-Chair, Venture Capital & Private Equity Practice

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Investor Relations Officer

Advised onHarvard Bioscience, Inc. purchases HEKA Elektronik Dr. Schulze GmbH

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded in November 2006 and is headquartered in Waltham, MA.

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Key Stats and Financials As of 2017
Market Capitalization
$132M
Total Enterprise Value
$121M
Earnings Per Share
$-0.02
Revenue
$102M
Net Profit
$-860K
EBITDA
$3.7M
EBITDAMargin
3.63%
Total Debt
$11.7M
Total Equity
$80.9M
Enterprise Value Sales
1.18x
Enterprise Value EBITDAOperating
32.62x
TEVNet Income
-139.54x
Debt TEV
0.1x
Three Year Compounded Annual Growth Rate Of Revenue
-2.13%
Five Year Compounded Annual Growth Rate Of Revenue
-1.73%
Investors
Details Hidden

NEP focuses on investing in companies in the technology, healthcare, and consumer product industries. Within the technology sector, they concentrate on investing in companies in the Internet, software, hardware and communications industries. In healthcare, they target biopharmaceutical, biotechnology, medical device and e-health companies. In consumer products, they seek companies that can offer distinctive products in a mass-market retail channel setting.The firm seeks early and later stage companies that are beyond the concept stage, have demonstrable technology and evidence of product or service acceptance. For companies with greater financial needs, NEP has a history of syndicating with other reputable venture capital or strategic investors. They participate in all stages of a company's equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO.NEP concentrates on investing in companies that target potentially large markets. In addition, they work closely with portfolio companies in setting goals and financial objectives to maximize the overall financial return of the company and its investors.They seek to invest in companies that offer the potential for a relatively early initial public offering or sale to a strategic buyer. They also assist their portfolio companies in achieving liquidity by way of a sale to a financial investor or through a recapitalization.

Details Hidden

Ascent Venture Management Inc. invest in early stage companies based in east coast US, cross Atlantic, Europe and Israel. It invests in Enterprise technology.

Details Hidden

First New England Capital (FNEC) invests in mezzanine and equity securities of middle market, later-stage companies across a variety of industries that have generated $10 million to $150 million of revenue and have demonstrated an ability to deliver strong operating performance and cash flow. They also consider investments in dynamic, fast-growing companies with a demonstrated ability to execute well-defined operating strategies. The firm seeks companies which have demonstrated a balance between sustainable growth and expense control.The firm prefers to invest in transactions that range in size from $2 million to $7 million. They may also make smaller investments in companies that have the potential for follow-on investment or larger investments in combination with other investment partners. Investments may be structured as current pay and/or payment-in-kind securities, preferred stock or common equity in conjunction with mezzanine capital.FNEC's capital is typically used to provide liquidity to founders and existing shareholders, to make acquisitions or finance organic growth. They will act as lead or participate as a member of larger syndicates. FNEC is often a minority investor. In most investments, FNEC requires board representation.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Marengo, IL

Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research and clinical tools that scientists use to study cells and cell components in order to understand the causes of diseases; identify new therapies; and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as provide dental consumables, equipment, and services. The Environmental & Applied Solution segment engages in the development and manufacture of equipment, consumables, and software for various printing, marking, coding, design, and color management applications for global and water supply industries. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

PerkinElmer, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. From multi-vendor laboratory services, software and informatics, to clinical lab testing and unparalleled customer care, we have the people, tools and resources to help customers solve their business and scientific goals. Our core competencies, coupled with our commitment to excellence, provide a strong foundation for delivering optimal service and support. By encouraging exploration, ingenuity and integrity, together with teamwork and employee development, at PerkinElmer we live our mission, every day

Becton, Dickinson & Co. Medical Products & Equipment - Franklin Lakes, New Jersey

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harvard Bioscience, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harvard Bioscience, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Harvard Bioscience, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/harvard-bioscience-inc-53905
  • https://relationshipscience.com/organization/harvard-bioscience-inc-53905